Showing results (51-60 of 67) with videos related to
Sort By:
Pageof 7
Oxidative Medicine and Cellular Longevity|April 17, 2013
Therapeutic effect of MG132 on the aortic oxidative damage and inflammatory response in OVE26 type 1 diabetic miceXiao Miao, Wenpeng Cui, Weixia Sun, et al.Toxicology Letters|May 14, 2013
Metallothionein prevention of arsenic trioxide-induced cardiac cell death is associated with its inhibition of mitogen-activated protein kinases activation in vitro and in vivoXiao Miao, Zefang Tang, Yonggang Wang, et al.Plos One|December 20, 2012
Diabetes-induced hepatic pathogenic damage, inflammation, oxidative stress, and insulin resistance was exacerbated in zinc deficient mouse modelChi Zhang, Xuemian Lu, Yi Tan, et al.Peptides|November 7, 2021
Effect of Fc-Elabela-21 on renal ischemia/reperfusion injury in mice: Mediation of anti-apoptotic effect via Akt phosphorylationFeng Xu, Man Wu, Xuehong Lu, et al.Diabetologia|April 27, 2016
C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21Hao Wu, Lili Kong, Yi Tan, et al.Molecular Biology Reports|June 19, 2012
Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: a systematic review and meta-analysisWenpeng Cui, Bing Du, Wenhua Zhou, et al.The American Journal of the Medical Sciences|February 5, 2011
Efficacy and safety of mizoribine combined with losartan in the treatment of IgA nephropathy: a multicenter, randomized, controlled studyYuansheng Xie, Songmin Huang, Li Wang, et al.Journal of Cellular and Molecular Medicine|December 17, 2013
Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathyYong Pan, Yi Huang, Zhe Wang, et al.Biochimica Et Biophysica Acta|December 3, 2014
Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylationYangwei Wang, Yonggang Wang, Manyu Luo, et al.Journal of Cancer Research and Clinical Oncology|June 16, 2012
Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?Linlin Liu, Nian Liu, Baogang Liu, et al.Pageof 7